300 million single cell atlas now accessible to the scientific community comprised of Vevo’s Tahoe-100M, mapping 60,000 drug-patient interactions, and Arc’s AI-curated scBaseCamp 200 million cell ...
SOUTH SAN FRANCISCO, Calif., Jan. 13, 2025 /PRNewswire/ -- Vevo Therapeutics, a biotechnology company using its Mosaic technology and next-generation AI to uncover better drugs for more patients, ...
Vevo's Mosaic platform is the first to make single-cell measurement of drug action across heterogeneous patients scalable The Tahoe-100M dataset, generated using Mosaic in partnership with the GigaLab ...
300 million single cell atlas now accessible to the scientific community comprised of Vevo's Tahoe-100M, mapping 60,000 drug-patient interactions, and Arc's AI-curated scBaseCamp 200 million cell ...